ClinicalTrials.gg
CompletedNCT05810272Updated Nov 19, 2026

Impact of Postprandial 'Exercise Snacks' on Protein and Glucose Metabolism Following a Period of Step Reduction in Older Adults

An interventional study of Metabolic Trial and 15 sit-to-stands with calf raises in Inactivity, Physical, Aging and Healthy Aging, sponsored by University of Toronto. Completed at 1 site in Canada. Open to participants aged 60 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by University of Toronto · Not applicable, Interventional, and Other

How we know

Updated Nov 19, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
60 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 73 studies in Sedentary Behavior with a site in Canada — 18 open to participants now, 19 under way, none of them phase 3. Sedentary Behavior · Canada.

Enrollment
55th of 69
20 · median 50
Started
2023
with 11 others
No phase
67 of 73
18 open now
Registered
54th of 73
by date
Lead sponsor
9 of 73
University of Toronto

Among the 73 studies in Sedentary Behavior with a site in Canada, this one is the 55th largest by enrollment of the 69 interventional ones that give a count, is one of 12 that started in 2023, is one of 67 with no phase, and was the 54th registered.

Sedentary Behavior

1,276 studies on the registry are indexed under Sedentary Behavior; 292 are open to participants now.

Browse Sedentary Behavior studies →

Open to participants now

18 of the 73 studies in Sedentary Behavior with a site in Canada are open now. Recruiting first, the newest first:

13 more — sign in →

All 18 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 184 Sedentary Behavior studies recruiting now, 77 (42%) set no upper age limit and 82 (45%) stop at 75 or younger; 30 take children under 18; 97 take healthy volunteers.

This study: 60 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 73 studies in Sedentary Behavior with a site in Canada, or all of them as a file.
02

Study summary

The purpose of this study is to assess the impact of 3-days reduced physical activity (\<1500 steps/day) with/without 'exercise snacks' (15 chair stands with calf raises every 30 min) on skeletal muscle metabolic health.

Read the detailed description

Many adults gradually lose muscle size, strength, and function after the age of 50. These losses are believed to occur faster with periods of reduced activity (e.g., lower step counts or physical movement when sick or injured) and can be difficult to regain by merely returning to a previously normal activity status. Such periods of reduced activity can also impair the body's ability to use the nutrients in the food consumed (e.g., proteins and carbohydrates), which increases the risk of frailty, type 2 diabetes, and ultimately a reduced quality of life. It is important to identify strategies to prevent these losses in muscle size, strength, and function especially during periods of reduced activity.

Recently, our laboratory has found that performing repeated bodyweight chair squats (repeated sit-to-stands with a calf raise) during a single day of reduced activity improves the muscle's ability to use carbohydrates and proteins, which may be a viable strategy to offset the negative effects of step reduction on muscle health.

In this study, the investigators will assess whether completing bodyweight chair squats at regular intervals (i.e., 'exercise snacks') reduces the negative effects of step reduction on carbohydrate and protein metabolism following a meal. The investigators will determine the impact of 'exercise snacks' (15 chair stands with calf raises every 30 min) compared to seated rest on protein and carbohydrate metabolism following three days of step reduction. The investigators will also assess how these responses compare to those seen following three days of normal (i.e., habitual) activity.

03

Conditions studied

  • Inactivity, Physical
  • Aging
  • Healthy Aging
  • Sarcopenia
  • Muscular Atrophy
  • Neuromuscular Manifestations
  • Neurologic Manifestations
  • Nervous System Diseases
  • Atrophy
  • Pathological Conditions, Anatomical

Keywords

  • Skeletal Muscle
  • Step-Reduction
  • Aging
  • Anabolic Resistance
  • Physical Activity
  • Stable Isotopes
04

Who can participate

Ages eligible
60 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy older (age: 60-80 y) adults
  • between normal to overweight (18.5-29.9 kg/m2)

Exclusion criteria

Exclusion Criteria:

  • Regular use of nonsteroidal anti-inflammatory drugs (with the exception of daily low-dose aspirin)
  • Alcohol consumption during the study period
  • Use of anticoagulants
  • Use of a walker, cane, or assistive walking device
  • Current or recently remised cancer
  • Infectious or gastrointestinal disease
  • Inability to comply with study protocol (e.g., >1,500 steps/day during Step-Reduction Phase)
  • Regular tobacco use
  • Self-reported illicit drug use (e.g. growth hormone, testosterone, etc.)
  • Diagnosed chronic illness (e.g. type 2 diabetes, heart disease, thyroid disease)
  • Hormonal Replacement Therapy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Other
    Habitual Activity

    Following three days of habitual activity, a metabolic trial will be completed wherein participants (10M/10F) will be assessed for their anabolic response to a protein-carbohydrate meal.

    Behavioral: Metabolic Trial

  • Experimental
    Step-Reduction

    Participants will undergo three days of reduced physical activity (\<1,500 steps/day) prior to a metabolic trial to establish their anabolic response to a protein-carbohydrate meal.

    Behavioral: Metabolic Trial · Behavioral: 15 sit-to-stands with calf raises

Interventions

  • BehavioralMetabolic Trial

    Participants will undergo a metabolic trial to assess for their anabolic response to a protein-carbohydrate meal.

  • Behavioral15 sit-to-stands with calf raises

    Participants (n=10; 5F/5M) will be randomized to perform 15 sit-to-stands with calf raises every 30 minutes for the 4 hour duration between muscle biopsies

    Also known as: Exercise Snacks

06

What researchers measure

Primary outcomes

  1. Myofibrillar protein synthesis rates

    Myofibrillar protein synthesis rates assessed by incorporation of oral stable isotope tracer in both arms.

    Time frame: 5 Hours

Secondary outcomes

  1. Whole-body protein turnover

    Whole-body protein turnover assessed by oral stable isotope tracers in both arms.

    Time frame: 5 Hours

  2. Amino acid oxidation and net protein balance

    Amino acid oxidation and net protein balance assessed by oral tracers in both arms. Net protein balance is derived from the difference between amino acid intake (known) and total amino acid oxidation over the 5h measurement period.

    Time frame: 5 Hours

  3. Postprandial insulin area under the curve (AUC) to mixed macronutrient breakfast

    The plasma insulin concentration measured by enzyme-linked immunosorbent assay (ELISA) area under the curve (AUC) will be quantified using the trapezoidal rule.

    Time frame: 5 Hours postprandial

  4. Postprandial glucose area under the curve (AUC) to mixed macronutrient breakfast

    The plasma glucose concentration measured by hexokinase method area under the curve (AUC) will be quantified using the trapezoidal rule.

    Time frame: 5 hours postprandial

07

Study locations

1 site
  • Goldring Center for High Performance Sport
    Toronto, Ontario M5S 2C9, Canada
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2023 to primary completion in Apr 2024, 12 months.

Of 736 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 30. This study's 12 months is below that.

Counting every sponsor, half of 744 studies reached it within 14 months; a quarter within 6 and three quarters within 30.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 19, 2026: primary completion Mar 2024 → Apr 2024 and completion Aug 2024 → Apr 2024.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 21, 2023
First posted
Apr 12, 2023
StartActual
Apr 1, 2023
Primary completionActual
Apr 30, 2024was Mar 2024
CompletionActual
Apr 30, 2024was Aug 2024
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 19, 2026
Primary completion
Mar 1, 2024→Apr 30, 2024 (actual)
Nov 19, 2026
Study completion
Aug 1, 2024→Apr 30, 2024 (actual)
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Recruiting→Completed
    Primary completion Mar 1, 2024→Apr 30, 2024 (now actual)
    Study completion Aug 1, 2024→Apr 30, 2024 (now actual)
    + 2 other changes: contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT05810272
Responsible party
Daniel Moore (Associate Professor in Muscle Physiology, University of Toronto) — Principal investigator
First posted
Apr 12, 2023
Start date
Apr 1, 2023
Primary completion
Apr 30, 2024
Completion
Apr 30, 2024
Last update
Nov 19, 2026

Study contacts

Daniel R Moore, PhD
principal investigator · University of Toronto
Hugo JW Fung, PhD
study director · University of Toronto

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion